Endocrinology, Vol 133, 2639-2644, Copyright © 1993 by Endocrine Society

ARTICLES

Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells

M Poutanen, M Miettinen and R Vihko
Biocenter, University of Oulu, Finland.

The metabolism of estrogens catalyzed by human placental 17 beta- hydroxysteroid dehydrogenase (17HSD) transiently expressed in COS-m6 cells was studied, and the properties of the enzyme were compared with those of an endogenous hydroxysteroid dehydrogenase (HSD) expressed in the cells. In cultured cells, the endogenous HSD had almost exclusively oxidative activity, converting estradiol to estrone (oxidative and reductive activity, 0.84 +/- 0.164 and 0.034 +/- 0.01 nmol/mg protein.h, respectively). This was, nevertheless, opposed to the activity of the transiently expressed human placental 17HSD, as a high reductive activity (0.86 +/- 0.30 nmol/mg protein.h) appeared in the cells after transfection, whereas oxidative activity was not significantly induced. In the different transfections, the reductive activity was induced 13- to 34-fold, and the oxidative activity in the 17HSD-transfected cells was 65-162% of that in the mock-transfected cells. Thus, in cultured cells, these two enzymes preferentially catalyze opposite reactions. When the metabolism of the estrogens was followed up to 20 h, the two enzymes were found to regulate the proportion of estrone to estradiol in the culture medium. The different properties found for the enzymes show that the endogenous HSD expressed in the COS-m6 cells is an additional member of the family of 17HSD enzymes. It is suggested that different 17HSD enzymes exist, with differential estrogen substrate specificities in cultured cells. Thus, in addition to cofactor and substrate availability, the biological activity of estrogens in different cell types may be regulated by the expression of different forms of 17HSD enzymes, resulting in the dominance of either estradiol or estrone production.

This article has been cited by other articles:

				T. Saloniemi, T. Lamminen, K. Huhtinen, M. Welsh, P. Saunders, H. Kujari, and M. Poutanen Activation of Androgens by Hydroxysteroid (17{beta}) Dehydrogenase 1 in Vivo as a Cause of Prenatal Masculinization and Ovarian Benign Serous Cystadenomas Mol. Endocrinol., November 1, 2007; 21(11): 2627 - 2636. [Abstract] [Full Text] [PDF]

				L Y Zhou, D S Wang, B Senthilkumaran, M Yoshikuni, Y Shibata, T Kobayashi, C C Sudhakumari, and Y Nagahama Cloning, expression and characterization of three types of 17{beta}-hydroxysteroid dehydrogenases from the Nile tilapia, Oreochromis niloticus J. Mol. Endocrinol., August 1, 2005; 35(1): 103 - 116. [Abstract] [Full Text] [PDF]

				T. E. Vaskivuo, M. Maentausta, S. Torn, O. Oduwole, A. Lonnberg, R. Herva, V. Isomaa, and J. S. Tapanainen Estrogen Receptors and Estrogen-Metabolizing Enzymes in Human Ovaries during Fetal Development J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3752 - 3756. [Abstract] [Full Text] [PDF]

				S. Deb, S. Amin, A. G. Imir, M. B. Yilmaz, T. Suzuki, H. Sasano, and S. E. Bulun Estrogen Regulates Expression of Tumor Necrosis Factor Receptors in Breast Adipose Fibroblasts J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4018 - 4024. [Abstract] [Full Text] [PDF]

				P. Harkonen, S. Torn, R. Kurkela, K. Porvari, A. Pulkka, A. Lindfors, V. Isomaa, and P. Vihko Sex Hormone Metabolism in Prostate Cancer Cells during Transition to an Androgen-Independent State J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 705 - 712. [Abstract] [Full Text] [PDF]

				M. R. James, T. C. Skaar, R. Y. Lee, A. MacPherson, J. A. Zwiebel, B. S. Ahluwalia, F. Ampy, and R. Clarke Constitutive Expression of the Steroid Sulfatase Gene Supports the Growth of MCF-7 Human Breast Cancer Cells in Vitro and in Vivo Endocrinology, April 1, 2001; 142(4): 1497 - 1505. [Abstract] [Full Text]

				S. Leivonen, Y.-s. Piao, H. Peltoketo, P. Numchaisrika, R. Vihko, and P. Vihko Identification of Essential Subelements in the hHSD17B1 Enhancer: Difference in Function of the Enhancer and That of the hHSD17BP1 Analog Is due to -480C and -486G Endocrinology, August 1, 1999; 140(8): 3478 - 3487. [Abstract] [Full Text]

				V. L. Green, V. Speirs, A. M. Landolt, P. M. Foy, and S. L. Atkin 17{beta}-Hydroxysteroid Dehydrogenase Type 1, 2, 3, and 4 Expression and Enzyme Activity in Human Anterior Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1340 - 1345. [Abstract] [Full Text]

				M. W. Sawicki, M. Erman, T. Puranen, P. Vihko, and D. Ghosh Structure of the ternary complex of human 17beta -hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+ PNAS, February 2, 1999; 96(3): 840 - 845. [Abstract] [Full Text] [PDF]

				J. Fomitcheva, M. E. Baker, E. Anderson, G. Y. Lee, and N. Aziz Characterization of Ke 6, a New 17beta -Hydroxysteroid Dehydrogenase, and Its Expression in Gonadal Tissues J. Biol. Chem., August 28, 1998; 273(35): 22664 - 22671. [Abstract] [Full Text] [PDF]

				P. Nokelainen, H. Peltoketo, R. Vihko, and P. Vihko Expression Cloning of a Novel Estrogenic Mouse 17{beta}-Hydroxysteroid Dehydrogenase/ 17-Ketosteroid Reductase (m17HSD7), Previously Described as a Prolactin Receptor-Associated Protein (PRAP) in Rat Mol. Endocrinol., July 1, 1998; 12(7): 1048 - 1059. [Abstract] [Full Text]

				A. M. Corbould, S. J. Judd, and R. J. Rodgers Expression of Types 1, 2, and 3 17{beta}-Hydroxysteroid Dehydrogenase in Subcutaneous Abdominal and Intra-Abdominal Adipose Tissue of Women J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 187 - 194. [Abstract] [Full Text]

				T. Puranen, M. Poutanen, D. Ghosh, R. Vihko, and P. Vihko Origin of Substrate Specificity of Human and Rat 17{beta}-Hydroxysteroid Dehydrogenase Type 1, Using Chimeric Enzymes and Site-Directed Substitutions Endocrinology, August 1, 1997; 138(8): 3532 - 3539. [Abstract] [Full Text]

				T. M. Penning Molecular Endocrinology of Hydroxysteroid Dehydrogenases Endocr. Rev., June 1, 1997; 18(3): 281 - 305. [Abstract] [Full Text]

				T. Puranen, M. Poutanen, D. Ghosh, P. Vihko, and R. Vihko Characterization of Structural and Functional Properties of Human 17{beta}-Hydroxysteroid Dehydrogenase Type 1 Using Recombinant Enzymes and Site-Directed Mutagenesis Mol. Endocrinol., January 1, 1997; 11(1): 77 - 86. [Abstract] [Full Text]